Oric Pharmaceuticals earnings were -$127.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ORIC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$36.3M, up 5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORIC reported annual earnings of -$127.8M, with 27% growth. The next ORIC earnings date is May 5, 2025.
Oric Pharmaceuticals Earnings Reports & History FAQ
What were Oric Pharmaceuticals's earnings last quarter?
On ORIC's earnings call on Invalid Date, Oric Pharmaceuticals (NASDAQ: ORIC) reported Q4 2024 earnings per share (EPS) of -$0.51, up 2% year over year. Total ORIC earnings for the quarter were -$36.31 million. In the same quarter last year, Oric Pharmaceuticals's earnings per share (EPS) was -$0.50.
The next ORIC earnings date is Invalid Date. Add ORIC to your watchlist to be reminded of Oric Pharmaceuticals's next earnings date.
Is Oric Pharmaceuticals profitable or losing money?
As of the last Oric Pharmaceuticals earnings report, Oric Pharmaceuticals is currently losing money. Oric Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$127.85 million, a 26.96% increase year over year.
What was ORIC's earnings growth in the past year?
As of Oric Pharmaceuticals's earnings date in Invalid Date, Oric Pharmaceuticals's earnings has grown year over year. ORIC earnings in the past year totalled -$127.85 million.
What are Oric Pharmaceuticals's earnings expectations?
The current EPS estimate for Oric Pharmaceuticals's earnings report in Invalid Date is -$0.44.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.